Back to Search Start Over

Axicorp Pharma GmbH secures contract for Pharmaceutical products - Completion of non-exclusive discount contracts according to Section 130a (8) SGB V for medicinal products with the active ingredient follitropin alfa (G03GA05) as part of a so-called open

Source :
Pivotal Sources. June 30, 2023
Publication Year :
2023

Abstract

Germany based Axicorp Pharma GmbH has secured contract from AOK - Rheinland-Pfalz/Saarland - Die Gesundheitskasse for Pharmaceutical products - Completion of non-exclusive discount contracts according to Section 130a (8) SGB [...]

Subjects

Subjects :
Follicle-stimulating hormone
Contract agreement
News, opinion and commentary

Details

Language :
English
Database :
Gale General OneFile
Journal :
Pivotal Sources
Publication Type :
News
Accession number :
edsgcl.755341616

Tools

Authors Abstract Subjects Details